The Future Tech Exhibition 2020 (FUTEX 2020) was held from September 24th to September 26th, 2020, with over 600 startup teams participating. Our first-in-class diabetes drug, PS1, was highly honored receiving the prestigious Future Tech Award, and earning recognition from numerous domestic experts. We firmly believe that in the near future, PS1...

- [NEWS] 青年日報 : NSTC Leads 8 Biomedical Startups to the 2025 North America BIO International Convention
- [NEWS] 中時新聞網 - 工商時報 : Emerging Stock Biotech Family Gains New Powerhouse; Pharmasaga Soars Over 100% on First Day of Listing
- [NEWS] 中時新聞網 : New Force in New Drug Stocks! Pharmasaga to List on Emerging Stock Market on 27th at Reference Price of NT$120
- [NEWS] 中時新聞網 - 工商時報 : Pharmasaga to List on Emerging Stock Market on 27th at Reference Price of NT$120
- [NEWS] 工商時報 : Emerging Stock Biotech Family Gains New Powerhouse; Pharmasaga Soars Over 100% on First Day of Listing
- [NEWS] 工商時報 : Pharmasaga to List on Emerging Stock Market on 27th at Reference Price of NT$120
- [NEWS] 自由時報-自由財金 : New Drug to Reverse Diabetes? Pharmasaga Expected to List on Emerging Stock Market on 27th at NT$120
- [NEWS] 自由時報 : New Drug to Reverse Diabetes? Pharmasaga Expected to List on Emerging Stock Market on 27th at NT$120
- [NEWS] 台灣新生報 : Pharmasaga to List on Emerging Stock Market Tomorrow at NT$120 Per Share
- [NEWS] TVBS新聞網 : Pharmasaga Develops Novel Diabetes Drug with 'Reversal Potential'; Listing on Emerging Stock Market on Nov. 27
- [NEWS] 壹蘋果新聞網 : Targeting the Multi-Billion-Dollar Diabetes Drug Market; Pharmasaga to List on Emerging Stock Market the Day After Tomorrow with New Drug Development
- [NEWS] 環球生技 : Pharmasaga's Innovative Drug for Type 1/2 Diabetes Plans Phase II, Creates Buzz Ahead of Emerging Stock Listing
- [NEWS] GENE ONLONE : Pharmasaga Pre-Listing Investor Conference: Diabetes New Drug Shows Reversal Effect in Animal Models
- [NEWS] 財訊快報 : Pharmasaga to List on Emerging Stock Market on 27th at Reference Price of NT$120; New Type 2 Diabetes Drug to Announce Phase Ib Clinical Data in H1 Next Year
- [NEWS] 發達網 : Pharmasaga to List on Emerging Stock Market on 27th; Type 2 Diabetes Phase Ib Clinical Trial Aims for Completion Next Year
- [NEWS]
自立晚報 : Pharmasaga Lists on Emerging Stock Market; Innovative Diabetes Reversal Therapy Targets Market
- [NEWS] anue鉅亨網 : Pharmasaga to List on Emerging Stock Market on November 27th at Reference Price of NT$120 Per Share
- [NEWS] anue鉅亨網 : Pharmasaga to List on Emerging Stock Market on November 27th at Reference Price of NT$120 Per Share
- [NEWS] 優分析 : Pharmasaga to List on Emerging Stock Market on November 27th at Reference Price of NT$120 Per Share
- [NEWS] 經濟日報 : Biotech Newcomer Pharmasaga Lists on Emerging Stock Market on 27th at NT$120; Developing Diabetes Reversal New Drug PS1 to Enter International Market
- [NEWS] 聚財網 : Biotech Newcomer Pharmasaga Lists on Emerging Stock Market on 27th at NT$120; Developing Diabetes Reversal New Drug PS1 to Enter International Market

